StockData
XORTX Therapeutics Inc. logo

XORTX Therapeutics Inc. (XRTX) stock

XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 0/30
$1.06+0.00 (0.00%)

Close on Nov 18, 2026Market cap $116.17KP/E –Yield –

XORTX Therapeutics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for XORTX Therapeutics

XORTX Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More XORTX Therapeutics figures

See a number that looks wrong?